Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Proton Pump Inhibitor
100%
Esomeprazole
66%
Fibrosing Alveolitis
54%
Dimethylargininase
38%
Malignant Neoplasm
35%
6 N,n' Dimethylarginine
26%
N(g),n(g) Dimethylarginine
26%
Cardiovascular Risk
24%
Lung Fibrosis
22%
Nitric Oxide
20%
Ionizing Radiation
20%
Enzyme
18%
Insulin
17%
Nitric Oxide Synthase
17%
Diseases
14%
Heme Oxygenase 1
13%
Lung Injury
12%
Pneumonia
12%
Gastroesophageal Reflux
12%
Pirfenidone
12%
Mouse Model
11%
Clinical Trial
10%
Skin Fibrosis
10%
Fibrosis
9%
Insulin Resistance
9%
Antiviral Activity
9%
HIV
9%
Scleroderma
9%
Anti-Human Immunodeficiency Virus
9%
Neoplasm
9%
microRNA
9%
Receptor Agonist
9%
Severe Acute Respiratory Syndrome
9%
Heart Muscle Fibrosis
9%
Growth Factor
9%
Dermatitis
9%
Dahl Rat
9%
Nuclear Factor
9%
Nicotine
9%
Poxviridae
9%
Farnesoid X Receptor
9%
Heart Stress
9%
Antiinfective Agent
9%
Drug Repositioning
9%
Heart Infarction
9%
Mitogen Activated Protein Kinase
9%
Insulin Sensitizing Agent
9%
Antivirus Agent
9%
Plant Extract
9%
Adverse Event
7%
Medicine and Dentistry
Proton-Pump Inhibitor
47%
Idiopathic Pulmonary Fibrosis
22%
Nitric Oxide
20%
N(g),n(g) Dimethylarginine
12%
Cardiovascular Risk
10%
Lung Fibroblast
10%
Diseases
9%
Nitrite
9%
Small Cell Lung Cancer
9%
Hyperplasia
9%
Doctor of Philosophy
9%
Myofibroblast
9%
Fluorescent Dye
9%
Nicotinic Receptor
9%
Radiation-Induced Lung Injury
9%
Restenosis
9%
Angiogenesis
9%
Gastroesophageal Reflux
7%
Lung
6%
Endothelium
5%
Enzymes
5%
Endothelial Cell
5%
Cancer Growth Factor
5%
Immunology and Microbiology
Cancer Cell
18%
Induced Pluripotent Stem Cell
14%
Endothelial Cells
14%
Complement Activation
12%
Gene Expression
9%
Human Immunodeficiency Virus
9%
Plant Extract
9%
Muscle Contractility
9%
Kidney Structure
9%
Endothelium
9%
Vascular Smooth Muscle Cell
9%
Sensitization
9%
Vascular Endothelial Cell
9%
Poxviridae
9%
Xenotransplantation
9%
Severe Acute Respiratory Syndrome
9%
Human Embryonic Stem Cell
9%
Vaccinia Virus Complement Control Protein
9%
In Vitro
7%
Hyperacute Graft Rejection
6%
Antiviral Activity
5%
Neck
5%